GlassScriptPhysician profile
David Lee Coffman
NPI 1174225791
$4,160.53
in general payments reported to CMS, 2019-2025
9 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,512 · 2024: $2,486 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $1,161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $1,160.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,000.00 | 2023-2024 | Davinci Xi |
| W. L. Gore & Associates, INC. | $238.02 | 2023-2025 | Gore Enform Preperitoneal Biomaterial, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Boston Scientific Corporation | $218.11 | 2024 | Exalt Model D, Spyglass Discover |
| Silk Road Medical, INC. | $171.89 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Integra Lifesciences Corporation | $159.38 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Medtronic, INC. | $142.84 | 2023 | Endurant Iis |
| Abbvie INC. | $121.96 | 2023 | Strattice Reconstructive Tissue Matrix Bps |
| Edwards Lifesciences Corporation | $83.84 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Lemaitre Vascular, INC. | $24.49 | 2024 | Artegraft Vascular Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Coffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.